Table 2.
Results of univariate and multivariate linear regression analysis between log10HOMA-IR and areal BMD (aBMD), volumetric BMD (vBMD), cortical bone ratio, Composite Strength Indices and blood markers.
Unadjusted | Adjusted for LBM | Adjusted for LBM and Age | |||||||
---|---|---|---|---|---|---|---|---|---|
β | p | R2 | β | p | R2 | β | p | R2 | |
DXA aBMD | |||||||||
Femoral neck | 0.054 | 0.604 | 0.003 | −0.064 | 0.540 | 0.113 | −0.064 | 0.531 | 0.162 |
Total hip | 0.000 | 0.997 | 0.000 | −0.096 | 0.365 | 0.075 | −0.096 | 0.359 | 0.111 |
Lumbar spine | −0.053 | 0.605 | 0.003 | −0.199 | 0.050 | 0.172 | −0.199 | 0.049 | 0.189 |
QCT aBMD | |||||||||
Femoral neck | |||||||||
total | −0.062 | 0.549 | 0.004 | −0.144 | 0.185 | 0.057 | −0.144 | 0.177 | 0.097 |
cortical | −0.047 | 0.648 | 0.002 | −0.103 | 0.350 | 0.027 | −0.103 | 0.346 | 0.050 |
trabecular | 0.008 | 0.942 | 0.000 | −0.050 | 0.645 | 0.027 | −0.051 | 0.644 | 0.041 |
Total hip | |||||||||
total | −0.015 | 0.888 | 0.000 | −0.097 | 0.367 | 0.055 | −0.098 | 0.358 | 0.095 |
cortical | −0.044 | 0.671 | 0.002 | −0.103 | 0.349 | 0.029 | −0.103 | 0.337 | 0.083 |
trabecular | 0.086 | 0.410 | 0.007 | −0.013 | 0.899 | 0.085 | −0.013 | 0.900 | 0.087 |
QCT vBMD | |||||||||
Femoral neck | |||||||||
total | −0.046 | 0.659 | 0.002 | −0.065 | 0.557 | 0.005 | −0.065 | 0.555 | 0.026 |
cortical | 0.085 | 0.415 | 0.007 | 0.088 | 0.426 | 0.007 | 0.088 | 0.416 | 0.052 |
trabecular | −0.019 | 0.855 | 0.000 | −0.022 | 0.840 | 0.000 | −0.023 | 0.837 | 0.031 |
cort.vol/tot.vol | −0.093 | 0.369 | 0.009 | −0.114 | 0.301 | 0.012 | −0.114 | 0.293 | 0.054 |
Total hip | |||||||||
total | −0.006 | 0.956 | 0.000 | −0.003 | 0.976 | 0.000 | −0.003 | 0.975 | 0.040 |
cortical | −0.049 | 0.636 | 0.002 | −0.107 | 0.329 | 0.029 | −0.107 | 0.328 | 0.047 |
trabecular | 0.040 | 0.703 | 0.002 | 0.023 | 0.835 | 0.004 | 0.023 | 0.836 | 0.015 |
cort.vol/tot.vol | −0.070 | 0.500 | 0.005 | −0.048 | 0.666 | 0.009 | −0.048 | 0.666 | 0.016 |
L3 vertebra | |||||||||
trabecular | −0.140 | 0.175 | 0.020 | −0.187 | 0.087 | 0.037 | −0.187 | 0.075 | 0.120 |
Composite Strength Indices | |||||||||
CSI | −0.360 | 0.000* | 0.130 | −0.319 | 0.003* | 0.143 | −0.320 | 0.002* | 0.186 |
BSI | −0.261 | 0.011* | 0.068 | −0.219 | 0.042* | 0.083 | −0.220 | 0.039* | 0.112 |
ISI | −0.397 | 0.000* | 0.158 | −0.373 | 0.000* | 0.162 | −0.374 | 0.000* | 0.197 |
Bone Turnover Markers | |||||||||
CTx-1 | 0.071 | 0.491 | 0.005 | 0.064 | 0.561 | 0.005 | 0.064 | 0.562 | 0.009 |
25(OH) Vitamin D3 | −0.002 | 0.984 | 0.000 | 0.028 | 0.798 | 0.007 | 0.028 | 0.798 | 0.024 |
PTH | 0.109 | 0.291 | 0.012 | 0.030 | 0.780 | 0.062 | 0.030 | 0.780 | 0.069 |
LBM: lean body mass, β: standardized β-coefficient, p: significance level, R2: R-squared of the model; DXA: dual X-ray absorptiometry, QCT: quantitative computed tomography, cort.vol/tot.vol: cortical to total volume ratio; CSI: compression strength index, BSI: bending strength index, ISI: impact strength index, CTx-1: C-telopeptide of Type I collagen, PTH: parathyroid hormone. * p < 0.05.